Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2025-11-25 00:00:00 ET · period of report 2025-11-24 · accession 0001982621-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-25 | 2025-11-24 | TLSI | Stevens Jennifer | Chief Regulatory Off | A - Grant | $0.00 | +50.0K | 127.6K | +64% | $0 |
| D | 2025-11-25 | 2025-11-24 | TLSI | Stevens Jennifer | Chief Regulatory Off | A - Grant | $0.00 | +100.0K | 323.8K | +45% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-24 | A | A | 50,000 | $0.00 | 127,640 | D | — | — | (F1) Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2025-11-24 | A | A | 100,000 | $0.00 | 323,782 | D | $5.55 · — to 2035-11-23 | 100,000 Common Stock | (F2) One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date. |